Colgate-Palmolive Co. (NYSE:CL) shares fell -0.15% in last trading session and ended the day at $66.08. CL Gross Margin is 58.70% and its has a return on assets of 18.40%. Colgate-Palmolive Co. (NYSE:CL) quarterly performance is 7.31%.
On 30 November, it was reported for exemplifying sustainability leadership in the evolution of green manufacturing, Colgate-Palmolive Co. (NYSE:CL) has been honored with the 2015 Ray Anderson Radical Industrialism Award. A leading global consumer products company, Colgate-Palmolive was celebrated at the U.S. Green Building Council’s Greenbuild Leadership Awards Luncheon held in Washington, D.C.
Luna Innovations Incorporated (NASDAQ:LUNA) ended the last trading day at $1.00. Company weekly volatility is calculated as 3.00% and price to cash ratio as 3.69. Luna Innovations Incorporated (NASDAQ:LUNA) showed a weekly performance of -5.66%.
On 09 December, Rent-A-Center, Inc. (NASDAQ:RCII) shares fell -1.38% and was closed at $15.74. RCII EPS growth in last 5 year was -6.40%. Rent-A-Center, Inc. (NASDAQ:RCII) year to date (YTD) performance is -55.48%.
Rent-A-Center (NASDAQ:RCII) had its price target reduced by analysts at BB&T Corp. from $30.00 to $25.00 in a report issued on Monday, AnalystRatings.Net reports. The firm presently has a “buy” rating on the stock. BB&T Corp.’s target price would indicate a potential upside of 48.37% from the company’s previous close.
Great Basin Scientific, Inc. (NASDAQ:GBSN) shares increased 7.23% in last trading session and ended the day at $0.12. GBSN has a return on assets of -200.00%. Great Basin Scientific, Inc. (NASDAQ:GBSN) quarterly performance is 18.91%.
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Great Basin Scientific, Inc. (“Great Basin” or the “Company”) (NASDAQ: GBSN). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) caters to the Healthcare space. Its weekly performance is -6.56%. On the last day of trading company shares ended up at $7.00. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) distance from 50-day simple moving average (SMA50) is -4.39%.
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, presented at the 27th Annual Piper Jaffray Healthcare Conference on December 1, 2015 at The New York Palace Hotel in New York, NY.